Sabine Bahn (University of Cambridge, Neuroscience, Institute of Biotechnology, Cambridge) - Disease biomarkers in first-onset schizophrenia.

Yishai Levin (University of Cambridge, Neuroscience, Institute of Biotechnology, Cambridge) - Discovery and validation of protein biomarkers for schizophrenia in blood using nLC-MSE and nLC-MRM.

Daniel Martins-de-Souza (Max-Planck-Institut für Psychiatrie, RG Proteomics and Biomarkers, München)  - Proteome analysis of brain tissue from schizophrenic patients.

Ferdinand von Eggeling (CUCA - Core Unit Chip Application, Institut für Humangenetik und Anthropologie, Jena) - Spatial resolved proteomics in cancer research.

Michel Salzet (Université des Sciences et Technologies de Lille, Laboratoire de Neuroimmunologie des Annélides, Lille) - MALDI imaging for clinical proteomic application.

Karl Mechtler (IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Protein Chemistry Facility, Vienna) - High precision quantitative proteomics using iTRAQ on an LTQ Orbitrap: a new mass spectrometric method combining the benefits of all.

Albert Heck (Netherlands Proteomics Center, Utrecht) - Phosphoproteomics: promises, deliverables and challenges.